Two days after pharma companies sounded an alarm that their investments were headed out of Europe, Novartis AG has announced ...

When an autoimmune disease disrupted the life of someone close to scientist Dario Gutierrez, an idea emerged for a new ...

Researchers from the University of Cincinnati filed for protection of an electrochemical aptamer-based biosensor technology ...

The Trump administration applied a 90-day hold on nation-specific tariffs, but a group of 26 House Democrats urged the ...

Scientists from the Machine Intelligence from Cortical Networks (MICRONS) consortium have published the microconnectome of a cubic millimeter of the mouse brain. This is the most complete map of this ...

In mammals, the fibroblast growth factor (FGF)-FGF receptor (FGFR) interactions control many physiological processes during ...

Researchers from George Washington University filed for protection of a system and method that leverages generative models, ...

Despite a sharp drop in March, total med-tech M&A deal value for the first quarter of 2025 remained significantly higher than last year’s, reaching $10.93 billion compared to $3.63 billion in Q1 2024, ...

With a promising IL-36 inhibitor for atopic dermatitis (AD, or eczema) at the phase II stage, Turn Therapeutics Inc. has gained $75 million in post-public commitments and meanwhile is pursuing a ...

Mutations in the oncogene KRAS are widespread in several human cancers, including pancreatic ductal adenocarcinomas (92%), colorectal carcinomas (49%) and lung adenocarcinomas (35%). These mutations ...

Biopharma dealmaking surged in the first quarter of 2025, totaling $66.86 billion, well ahead of the $44.16 billion recorded in the same period last year. March contributed $29.48 billion to the total ...

Cardiovia Ltd.' Viaone epicardial access system received U.S. FDA clearance for treating cardiac arrhythmias. The device provides clinicians with a safe and minimally invasive technology to reach the ...